Molinalogo

Measure

2023 Rate

2023 Goal

2024 Rate

2024 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

69.05%

64.90%

0.00%

66.15%

Annual Dental Visits (ADV) Total

NB

54.60%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

52.09%

46.74%

35.42%

48.16%

Appropriate Testing for Pharyngitis (CWP)

74.26%

77.56%

84.08%

85.11%

Appropriate Treatment for Upper Respiratory Infection (URI) Total

94.06%

93.08%

93.17%

91.27%

Asthma Medication Ratio (AMR) Total

63.59%

69.41%

65.61%

70.56%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

77.33%

66.19%

78.76%

67.03%

Blood Pressure Control (<140/90) for Patients With Diabetes (BPD)

54.99%

68.61%

61.56%

71.78%

Breast Cancer Screening (BCS)

34.58%

55.25%

Breast Cancer Screening (BCS-E)

34.39%

54.94%

39.21%

56.66%

Cervical Cancer Screening (CCS)

44.04%

59.85%

42.18%

60.10%

Childhood Immunization Status (CIS) Combination #10

22.63%

35.04%

29.93%

31.32%

Chlamydia Screening in Women (CHL) Total

37.39%

61.07%

38.65%

61.46%

Controlling High Blood Pressure (CBP)

40.88%

65.45%

52.55%

67.40%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

78.22%

80.86%

80.75%

83.51%

Eye Exam for Patients With Diabetes (EED)

46.72%

56.20%

49.45%

57.09%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

NB

27.73%

NA

27.62%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

NB

46.35%

NA

44.33%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

NB

41.03%

NA

42.86%

Follow-Up After High-Intensity Care for Substance Use Disorder (FUI) 7-Day Follow-Up Total

NB

37.31%

NA

37.64%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

NB

57.90%

30.56%

56.86%

Follow-Up for Children Prescribed ADHD Medication (ADD-E) Continuation and Maintenance Phase

30.56%

56.83%

Hemoglobin A1c Control for Patients With Diabetes (HBD) HbA1c Control (<8%)

44.04%

55.72%

53.53%

59.64%

Immunizations for Adolescents (IMA) Combination #2

23.11%

38.93%

27.64%

38.69%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Total

NB

16.94%

NA

16.78%

Kidney Health Evaluation for Patients with Diabetes (KED)

31.80%

38.80%

34.57%

42.10%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Blood Glucose and Cholesterol Testing Total

21.73%

39.01%

23.46%

41.92%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM-E) Blood Glucose and Cholesterol Testing Total

23.46%

41.41%

Pharmacotherapy for Opioid Use Disorder (POD) Total

13.51%

31.93%

7.31%

29.01%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

60.71%

75.79%

60.53%

74.78%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

76.79%

86.96%

71.05%

86.54%

Plan All-Cause Readmissions (PCR) Observed-to-Expected Ratio 18-64 Years

66.38%

≤ 92.72%

76.25%

≤ 91.24%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

76.40%

86.86%

72.84%

86.89%

Prenatal and Postpartum Care (PPC) Postpartum Care

72.02%

80.78%

73.43%

82.48%

Prenatal Immunization Status (PRS) Combination Rate

16.53%

25.81%

Prenatal Immunization Status (PRS-E) Combination Rate

16.53%

25.81%

20.89%

24.92%

Risk of Continued Opioid Use (COU) 31-Day Total

3.97%

≤ 2.45%

4.68%

≤ 2.79%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

70.59%

81.64%

66.18%

83.00%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

60.42%

73.63%

60.00%

74.07%

Statin Therapy for Patients with Diabetes (SPD)

Received Statin Therapy

54.98%

67.07%

56.87%

67.01%

Statin Therapy for Patients with Diabetes (SPD)

Statin Adherence 80%

62.99%

70.37%

55.08%

70.91%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

NB

63.89%

NA

64.10%

Use of Imaging Studies for Low Back Pain (LBP)

74.19%

75.44%

71.58%

72.74%

Use of Opioids at High Dosage (HDO)

3.05%

≤ 2.19%

3.27%

≤ 2.14%

Use of Opioids from Multiple Providers (UOP)

Multiple Prescribers and Multiple Pharmacies

0.79%

≤ 0.87%

1.25%

≤ 1.22%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

54.99%

83.21%

66.91%

86.20%